← Open Payments lookup

SARAH SEELYE: Open Payments

NPI 1750780102 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$844 in 31 payments from 14 companies in 2025. Trend: 2023 $374 · 2024 $926 · 2025 $844

Food & beverage: $844
CompanyPaymentsAmount
Lilly USA, LLC5$164
Dexcom, Inc.4$147
AstraZeneca Pharmaceuticals LP3$142
GENZYME CORPORATION1$88
Sumitomo Pharma America, Inc.1$49
Astellas Pharma US Inc3$49
Novo Nordisk Inc3$47
Organon LLC3$39
Boehringer Ingelheim Pharmaceuticals, Inc.2$35
ABBVIE INC.1$29

Products named: Dexcom G6 Transmitter, ZEPBOUND, AIRSUPRA, DUPIXENT, GEMTESA, JARDIANCE, Veozah, NEXPLANON.

Industry payments across TX — which companies pay providers there.